629 related articles for article (PubMed ID: 24736263)
21. Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement.
Hackner K; Hütter L; Flick H; Grohs M; Kastrati K; Kiener H; Lang D; Mosheimer-Feistritzer B; Prosch H; Rath E; Schindler O; Moazedi-Fürst F
Z Rheumatol; 2024 Mar; 83(2):160-168. PubMed ID: 38240817
[TBL] [Abstract][Full Text] [Related]
22. Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?
Akiyama M; Alshehri W; Kaneko Y
Autoimmun Rev; 2024 Feb; 23(2):103501. PubMed ID: 38086437
[TBL] [Abstract][Full Text] [Related]
23. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
[TBL] [Abstract][Full Text] [Related]
24. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Koduri G; Solomon JJ
Arthritis Rheumatol; 2023 Dec; 75(12):2067-2077. PubMed ID: 37395725
[TBL] [Abstract][Full Text] [Related]
25. Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.
Maniwa K; Ogushi F; Tani K; Ohmoto Y; Muraguchi M; Sone S
Respirology; 2000 Dec; 5(4):315-20. PubMed ID: 11192540
[TBL] [Abstract][Full Text] [Related]
26. Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD).
Yu M; Guo Y; Zhang P; Xue J; Yang J; Cai Q; You X; Ma J; Yang D; Jia Y; Wang Y; Li F; Chi S; Cao M; Chen J; Liu X
Immunobiology; 2019 Jul; 224(4):551-559. PubMed ID: 31072629
[TBL] [Abstract][Full Text] [Related]
27. [Subclinical interstitial lung disease associated with rheumatoid arthritis].
Bestaev DV
Ter Arkh; 2014; 86(5):106-8. PubMed ID: 25026811
[TBL] [Abstract][Full Text] [Related]
28. Combination treatment with Janus kinase inhibitor and nintedanib for rheumatoid arthritis with progressive interstitial lung disease: A case report.
Mochizuki T; Yano K; Ikari K; Okazaki K
Mod Rheumatol Case Rep; 2023 Jun; 7(2):350-353. PubMed ID: 37061836
[TBL] [Abstract][Full Text] [Related]
29. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.
Kim Y; Yang HI; Kim KS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833957
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease.
Johnson C
Curr Opin Rheumatol; 2017 May; 29(3):254-259. PubMed ID: 28207496
[TBL] [Abstract][Full Text] [Related]
31. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.
Cavagna L; Monti S; Grosso V; Boffini N; Scorletti E; Crepaldi G; Caporali R
Biomed Res Int; 2013; 2013():759760. PubMed ID: 24205507
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y; Wang W; Yu Y; Hu S
Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
[TBL] [Abstract][Full Text] [Related]
33. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.
Brito Y; Glassberg MK; Ascherman DP
Curr Rheumatol Rep; 2017 Nov; 19(12):79. PubMed ID: 29119259
[TBL] [Abstract][Full Text] [Related]
34. Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China.
Liu L; Fang C; Sun B; Bao R; Zhang H
Int J Rheum Dis; 2022 Jul; 25(7):795-802. PubMed ID: 35633522
[TBL] [Abstract][Full Text] [Related]
35. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.
Fu Q; Wang L; Li L; Li Y; Liu R; Zheng Y
Clin Rheumatol; 2019 Apr; 38(4):1109-1116. PubMed ID: 30535993
[TBL] [Abstract][Full Text] [Related]
37. Interstitial lung disease throughout the rheumatoid arthritis disease course.
McDermott GC; Doyle TJ; Sparks JA
Curr Opin Rheumatol; 2021 May; 33(3):284-291. PubMed ID: 33625044
[TBL] [Abstract][Full Text] [Related]
38. Fragmented gelsolins are increased in rheumatoid arthritis-associated interstitial lung disease with usual interstitial pneumonia pattern.
Suhara K; Miyazaki Y; Okamoto T; Ishizuka M; Tsuchiya K; Inase N
Allergol Int; 2016 Jan; 65(1):88-95. PubMed ID: 26666486
[TBL] [Abstract][Full Text] [Related]
39. Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.
Yang G; Lyu L; Wang X; Bao L; Lyu B; Lin Z
Pulm Pharmacol Ther; 2019 Jun; 56():69-74. PubMed ID: 30930172
[TBL] [Abstract][Full Text] [Related]
40. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.
Kim EJ; Collard HR; King TE
Chest; 2009 Nov; 136(5):1397-1405. PubMed ID: 19892679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
